Top compounds associated with response to CCDC169-SOHLH2


Feature Type Standardized
Nominal ANOVA
mRNA PF-3758309 CTRPv2 pan-cancer AAC 0.093 0.03
mRNA SRT-1720 CTRPv2 pan-cancer AAC -0.078 0.03
mRNA ABT-199 CTRPv2 pan-cancer AAC -0.092 0.03
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.03
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.04
mRNA barasertib CTRPv2 pan-cancer AAC -0.065 0.04
mRNA CHM-1 CTRPv2 pan-cancer AAC 0.065 0.04
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.065 0.04
mRNA BRD-K49290616 CTRPv2 pan-cancer AAC -0.15 0.04
mRNA GSK2636771 CTRPv2 pan-cancer AAC -0.085 0.04
Download CSV